Companies Dominating the Coumarin Landscape
- Atlas Fine Chemicals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Omkar Speciality Chemicals
- N.S.Chemicals
- Bristol Myers Squibb
- Yingyang Flavors & Fragrance
- Anhui Jinpeng Flavours & Fragrances
- China Tuhsu
- Changzhou XinTongLi Chemicals
- Wuhan Sincere-star Chemical
- Saichuang Technology
- Botai (Tianjin) Fine Chemical
Browse Key Market Insights with Data Illustration:
In the News
- Bristol Myers Squibb acquired Mirati Therapeutics, Inc. to introduce KRAZATI a significant medication for lung cancer to gain access to several intriguing clinical assets that enhance its pipeline for oncology treatments and to make sure that Mirati's range of cutting-edge medications can assist patients everywhere.
- Merck & Co. along with Kelun-Biotech to collaborate with the pharmaceutical company on more sophisticated antibody-drug conjugates, and grant it the right to seven antibody-drug conjugates, which are early-stage medicines.
